期刊
PEST MANAGEMENT SCIENCE
卷 79, 期 1, 页码 183-193出版社
JOHN WILEY & SONS LTD
DOI: 10.1002/ps.7187
关键词
afoxolaner; laboratory selection; cross-resistance; gamma-Aminobutyric acid-gated chloride channel; Tetranychus urticae; two-electrode voltage-clamp electrophysiology
Afoxolaner demonstrated strong antagonistic activity against GABACls of T. urticae, making it a powerful tool for controlling spider mites. In contrast, other drugs such as fluralaner, fipronil, and endosulfan showed minimal antagonistic activities against GABACls channels of T. urticae.
BACKGROUND: Afoxolaner is a novel representative of the isoxazolines, a class of ectoparasiticides which has been commercialized for the control of tick and flea infestations in dogs. In this study, the biological efficacy of afoxolaner against the two-spotted spider mite Tetranychus urticae was evaluated. Furthermore, as isoxazolines are known inhibitors of gamma-aminobutyric acid-gated chloride channels (GABACls), the molecular mode of action of afoxolaner on T. urticae GABACls (TuRdls) was studied using functional expression in Xenopus oocytes followed by two-electrode voltage-clamp (TEVC) electrophysiology, and results were compared with inhibition by fluralaner, fipronil and endosulfan. To examine the influence of known GABACl resistance mutations, H301A, I305T and A350T substitutions in TuRdl1 and a S301A substitution in TuRdl2 were introduced. RESULTS: ioasassays revealed excellent efficacy of afoxolaner against all developmental stages no cross-resistance was found in a panel of strains resistant to most currently used acaricides. Laboratory selection over a period of 3 years did not result in resistance. TEVC revealed clear antagonistic activity of afoxolaner and fluralaner for all homomeric TuRdl1/2/3 channels. The introduction of single, double or triple mutations to TuRdl1 and TuRdl2 did not lower channel sensitivity. By contrast, both endosulfan and fipronil had minimal antagonistic activities against TuRdl1/2/3, and channels carrying single mutations, whereas the sensitivity of double and triple TuRdl1 mutants was significantly increased. CONCLUSIONS: Our results demonstrate that afoxolaner is a potent antagonist of GABACls of T. urticae and has a powerful mode of action to control spider mites. (c) 2022 Society of Chemical Industry.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据